Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) EPS (Basic) (2016 - 2025)

iBio (IBIO) has disclosed EPS (Basic) for 16 consecutive years, with -$0.08 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 83.33% to -$0.08 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.0, a 156.41% decrease, with the full-year FY2025 number at -$1.75, up 56.58% from a year prior.
  • EPS (Basic) was -$0.08 for Q4 2025 at iBio, up from -$0.11 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $1.4 in Q2 2024 to a low of -$60.19 in Q2 2023.
  • A 5-year average of -$4.03 and a median of -$0.7 in 2023 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): skyrocketed 114.98% in 2022, then tumbled 14097.67% in 2023.
  • iBio's EPS (Basic) stood at -$1.37 in 2021, then rose by 21.17% to -$1.08 in 2022, then plummeted by 309.26% to -$4.42 in 2023, then surged by 89.14% to -$0.48 in 2024, then soared by 83.33% to -$0.08 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's EPS (Basic) are -$0.08 (Q4 2025), -$0.11 (Q3 2025), and -$0.32 (Q2 2025).